vs
ACACIA RESEARCH CORP（ACTG）与Day One Biopharmaceuticals, Inc.（DAWN）财务数据对比。点击上方公司名可切换其他公司
ACACIA RESEARCH CORP的季度营收约是Day One Biopharmaceuticals, Inc.的1.3倍（$50.1M vs $39.8M），ACACIA RESEARCH CORP净利率更高（6.8% vs -49.6%，领先56.4%），ACACIA RESEARCH CORP同比增速更快（2.6% vs -57.6%）
槐亚研究公司是一家总部位于纽约市的美国上市企业，在科技、能源以及工业制造领域开展业务收购与运营工作。该公司与控股股东斯塔博德价值投资合伙企业保持战略伙伴关系，这家企业在业内常被归类为专利流氓。
Day One Biopharmaceuticals是一家临床阶段生物制药公司，专注于为患有基因驱动型癌症的儿童及年轻成人患者开发精准靶向肿瘤疗法，推进创新候选药物研发，满足相关群体未被覆盖的医疗需求，主要在美国市场开展业务。
ACTG vs DAWN — 直观对比
营收规模更大
ACTG
是对方的1.3倍
$39.8M
营收增速更快
ACTG
高出60.2%
-57.6%
净利率更高
ACTG
高出56.4%
-49.6%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $50.1M | $39.8M |
| 净利润 | $3.4M | $-19.7M |
| 毛利率 | 12.8% | — |
| 营业利润率 | -26.1% | -60.9% |
| 净利率 | 6.8% | -49.6% |
| 营收同比 | 2.6% | -57.6% |
| 净利润同比 | 125.5% | -153.3% |
| 每股收益（稀释后） | $0.03 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTGDAWN
| Q4 25 | $50.1M | — | ||
| Q3 25 | $59.4M | $39.8M | ||
| Q2 25 | $51.2M | $33.9M | ||
| Q1 25 | $124.4M | $30.8M | ||
| Q4 24 | $48.8M | — | ||
| Q3 24 | $23.3M | $93.8M | ||
| Q2 24 | $25.8M | — | ||
| Q1 24 | $24.3M | $0 |
净利润ACTGDAWN
| Q4 25 | $3.4M | — | ||
| Q3 25 | $-2.7M | $-19.7M | ||
| Q2 25 | $-3.3M | $-30.3M | ||
| Q1 25 | $24.3M | $-36.0M | ||
| Q4 24 | $-13.4M | — | ||
| Q3 24 | $-14.0M | $37.0M | ||
| Q2 24 | $-8.4M | — | ||
| Q1 24 | $-186.0K | $-62.4M |
毛利率ACTGDAWN
| Q4 25 | 12.8% | — | ||
| Q3 25 | 21.2% | — | ||
| Q2 25 | 12.8% | — | ||
| Q1 25 | 47.4% | — | ||
| Q4 24 | 17.6% | — | ||
| Q3 24 | 10.1% | — | ||
| Q2 24 | 26.2% | — | ||
| Q1 24 | 49.2% | — |
营业利润率ACTGDAWN
| Q4 25 | -26.1% | — | ||
| Q3 25 | -10.8% | -60.9% | ||
| Q2 25 | -24.2% | -103.1% | ||
| Q1 25 | 30.8% | -133.5% | ||
| Q4 24 | -32.4% | — | ||
| Q3 24 | -44.1% | 31.6% | ||
| Q2 24 | -18.4% | — | ||
| Q1 24 | -8.6% | — |
净利率ACTGDAWN
| Q4 25 | 6.8% | — | ||
| Q3 25 | -4.6% | -49.6% | ||
| Q2 25 | -6.4% | -89.4% | ||
| Q1 25 | 19.5% | -117.0% | ||
| Q4 24 | -27.5% | — | ||
| Q3 24 | -60.0% | 39.5% | ||
| Q2 24 | -32.7% | — | ||
| Q1 24 | -0.8% | — |
每股收益（稀释后）ACTGDAWN
| Q4 25 | $0.03 | — | ||
| Q3 25 | $-0.03 | $-0.19 | ||
| Q2 25 | $-0.03 | $-0.29 | ||
| Q1 25 | $0.25 | $-0.35 | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.14 | $0.38 | ||
| Q2 24 | $-0.08 | — | ||
| Q1 24 | $0.00 | $-0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $306.7M | $451.6M |
| 总债务越低越好 | $91.9M | — |
| 股东权益账面价值 | $543.5M | $450.9M |
| 总资产 | $771.0M | $513.8M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资ACTGDAWN
| Q4 25 | $306.7M | — | ||
| Q3 25 | $301.8M | $451.6M | ||
| Q2 25 | $316.7M | $453.1M | ||
| Q1 25 | $272.0M | $473.0M | ||
| Q4 24 | $273.9M | — | ||
| Q3 24 | $410.9M | $558.4M | ||
| Q2 24 | $441.9M | — | ||
| Q1 24 | $498.4M | $317.9M |
总债务ACTGDAWN
| Q4 25 | $91.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACTGDAWN
| Q4 25 | $543.5M | — | ||
| Q3 25 | $537.6M | $450.9M | ||
| Q2 25 | $538.6M | $460.8M | ||
| Q1 25 | $540.2M | $479.5M | ||
| Q4 24 | $514.8M | — | ||
| Q3 24 | $540.2M | $555.5M | ||
| Q2 24 | $560.7M | — | ||
| Q1 24 | $568.3M | $296.8M |
总资产ACTGDAWN
| Q4 25 | $771.0M | — | ||
| Q3 25 | $768.9M | $513.8M | ||
| Q2 25 | $775.5M | $519.0M | ||
| Q1 25 | $801.6M | $534.4M | ||
| Q4 24 | $756.4M | — | ||
| Q3 24 | $707.6M | $600.8M | ||
| Q2 24 | $753.6M | — | ||
| Q1 24 | $631.7M | $326.6M |
负债/权益比ACTGDAWN
| Q4 25 | 0.17× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.2M | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 22.01× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACTGDAWN
| Q4 25 | $75.2M | — | ||
| Q3 25 | $9.5M | $-5.8M | ||
| Q2 25 | $50.1M | $-24.8M | ||
| Q1 25 | $2.4M | $-59.0M | ||
| Q4 24 | $50.1M | — | ||
| Q3 24 | $-593.0K | $50.8M | ||
| Q2 24 | $16.1M | — | ||
| Q1 24 | $54.8M | $-49.7M |
自由现金流ACTGDAWN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-24.8M | ||
| Q1 25 | $335.0K | $-59.3M | ||
| Q4 24 | $-98.5M | — | ||
| Q3 24 | $-2.8M | $50.0M | ||
| Q2 24 | $-126.7M | — | ||
| Q1 24 | $54.6M | — |
自由现金流率ACTGDAWN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -73.2% | ||
| Q1 25 | 0.3% | -192.8% | ||
| Q4 24 | -201.8% | — | ||
| Q3 24 | -12.1% | 53.4% | ||
| Q2 24 | -490.5% | — | ||
| Q1 24 | 224.4% | — |
资本支出强度ACTGDAWN
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 1.7% | 1.0% | ||
| Q4 24 | 304.4% | — | ||
| Q3 24 | 9.6% | 0.8% | ||
| Q2 24 | 553.0% | — | ||
| Q1 24 | 1.1% | — |
现金转化率ACTGDAWN
| Q4 25 | 22.01× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.37× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACTG
| Energy Operations | $16.0M | 32% |
| Transportation Safety | $10.4M | 21% |
| Office Storage And Display Solutions | $8.4M | 17% |
| Printers Consumables And Parts | $6.5M | 13% |
| Natural Gas Reserves | $5.1M | 10% |
| Natural Gas Liquids Reserves | $3.3M | 7% |
DAWN
| Products | $38.5M | 97% |
| License Agreement With Ipsen Pharma Sas | $1.3M | 3% |
